What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Internal medicine
Anthony M. Jevnikar mainly focuses on Immunology, Transplantation, Antigen, T cell and Kidney.
His studies deal with areas such as NKG2D and Nod as well as Immunology.
His Transplantation study combines topics in areas such as Reperfusion injury, Necrosis, Monoclonal antibody and Necroptosis.
His study in T cell is interdisciplinary in nature, drawing from both Molecular biology and Major histocompatibility complex.
His Kidney research incorporates themes from Interleukin 21, Janus kinase 3, Perforin, Pharmacology and Renal ischemia.
His Immunosuppression research includes themes of Antibody and Kidney transplantation.
His most cited work include:
- Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. (569 citations)
- Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. (277 citations)
- Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. (277 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Immunology, Transplantation, Kidney, Antigen and Internal medicine.
His study in T cell, Immune system, Adoptive cell transfer, Antibody and MHC class II falls under the purview of Immunology.
Anthony M. Jevnikar has included themes like Reperfusion injury, Immunosuppression and Pharmacology in his Transplantation study.
His work deals with themes such as Apoptosis, Cancer research, Transplant rejection and Renal ischemia, which intersect with Kidney.
The Antigen study combines topics in areas such as Molecular biology, Arthritis and Antigen-presenting cell.
His work in Internal medicine addresses subjects such as Endocrinology, which are connected to disciplines such as Cytokine.
He most often published in these fields:
- Immunology (66.81%)
- Transplantation (58.95%)
- Kidney (27.07%)
What were the highlights of his more recent work (between 2012-2021)?
- Transplantation (58.95%)
- Cancer research (16.16%)
- Immunology (66.81%)
In recent papers he was focusing on the following fields of study:
Transplantation, Cancer research, Immunology, Kidney and Necroptosis are his primary areas of study.
His Transplantation research is multidisciplinary, incorporating elements of Reperfusion injury, Ischemia, Immune system and Cell biology.
His Immunology research incorporates elements of Molecular biology and Anti cd40.
His primary area of study in Kidney is in the field of Kidney transplantation.
In his study, Inflammation, Alloimmunity and Transplant rejection is strongly linked to Necrosis, which falls under the umbrella field of Necroptosis.
The concepts of his Cytotoxic T cell study are interwoven with issues in Antigen, Virus, Graft loss and FOXP3.
Between 2012 and 2021, his most popular works were:
- RIPK3-Mediated Necroptosis Promotes Donor Kidney Inflammatory Injury and Reduces Allograft Survival (139 citations)
- RIPK3-Mediated Necroptosis Promotes Donor Kidney Inflammatory Injury and Reduces Allograft Survival (139 citations)
- Necroptosis in Immunity and Ischemia-Reperfusion Injury (121 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Immune system
His scientific interests lie mostly in Cancer research, Inflammation, Transplantation, Kidney and Necroptosis.
The subject of his Inflammation research is within the realm of Immunology.
His Transplantation study incorporates themes from Reperfusion injury and Ischemia.
In his study, Gene silencing, Kidney metabolism, CXCL1, Renal function and Kidney transplantation is inextricably linked to Pharmacology, which falls within the broad field of Ischemia.
He has researched Kidney in several fields, including Proinflammatory cytokine and Cytotoxic T cell.
His study looks at the intersection of Necroptosis and topics like Alloimmunity with RIPK1 and Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
